Chiron Corporation was established as the multinational biotechnological enterprise having its headquarters based in Emeryville of California sometimes during the year 1981 by three professors named William Rutter, Edward Penhoet and Pablo Valenzuela.  The company was however, taken over by Novartis International AG on the 20^th of April in the year 2006 with its offices and business set-ups in 18 nations of all the 5 continents. At that point, Chiron’s premier focus was on three major sectors such as Biopharmaceuticals, Vaccines and Blood Testing of which the Vaccines and Blood Testing sectors were amalgamated forming new entity named as Novartis Vaccines & Diagnostics, whereas the Biopharmaceuticals division of Chiron would be incorporated into Novartis Pharmaceuticals.  

 

Chiron basically is focusing on averting transfusion or transmission caused infections. The company is poised to develop latest tools, products and services for safeguarding the world-wide blood supply being the leader in blood safety for the transfusion industry. When the scientists at Chiron initially recognized the hepatitis C virus leading to the development of the preliminary test for screening blood for HCV, enjoys the bequest of captaincy in the blood safety business since 1986. Chiron is the boss in Nucleic Acid Testing for blood screening and its PORCLEIX products are widely used for testing over 25 million blood donations every year in different countries of the world for averting numerous HIV-1, Hepatitis & West Nile Virus transmitted infections.      

 

The main products of Chiron include:

 

• Instruments sector – PROCLEIX / TIGRIS process
• Software sector – PROCLEIX / NAT TRACKER & PROCLEIX Pooling software

Assays – PROCLEIX / WNV Assay, PROCLEIX HIV-1 & HCV Assay and PROCLEIX / ULTRIO Assay.